Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 12/20 | 0.78 |
| ▸ | SLC6A2 | P23975 | 4/20 | 0.78 |
| ▸ | SLC6A3 | Q01959 | 4/20 | 0.78 |
| ▸ | HTR6 | P50406 | 2/20 | 0.56 |
| ▸ | HTR1A | P08908 | 1/20 | 0.44 |
| ▸ | DRD1 | P21728 | 1/20 | 0.44 |
| ▸ | HTR1B | P28222 | 1/20 | 0.44 |
| ▸ | HTR2A | P28223 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9126761 | 0.88 | SLC6A4 (1.00) | SLC6A4SLC6A2SLC6A3HTR6HTR1A | |
| SCHEMBL9130289 | 0.81 | SLC6A4 (0.66) | SLC6A4SLC6A2SLC6A3HTR6HTR1A | |
| SCHEMBL9128688 | 0.79 | SLC6A4 (0.71) | SLC6A4SLC6A2SLC6A3HTR6 | |
| SCHEMBL7483841 | 0.78 | SLC6A4 (0.67) | SLC6A4SLC6A2SLC6A3HTR6 | |
| SCHEMBL9133062 | 0.77 | SLC6A4 (0.67) | SLC6A4SLC6A2SLC6A3HTR6 | |
| SCHEMBL9129397 | 0.77 | SLC6A4 (0.66) | SLC6A4SLC6A2SLC6A3HTR6HTR1A | |
| SCHEMBL4880407 | 0.72 | HTR6 (1.00) | SLC6A4SLC6A2SLC6A3HTR6 | |
| SCHEMBL9130983 | 0.71 | SLC6A4 (0.60) | SLC6A4SLC6A2SLC6A3HTR6HTR1A | |
| SCHEMBL6639190 | 0.71 | HTR6 (0.67) | SLC6A4SLC6A2SLC6A3HTR6HTR1A | |
| SCHEMBL1122074 | 0.71 | SLC6A4 (1.00) | SLC6A4HTR6HTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5468767-A | FOR ADMINISTERING TO MAMMALS | BRISTOL-MYERS SQUIBB COMPANY (US) | 1995-11-21 | — | — | US | claimed |